Likewise, in T2DM patients, Duflot et al. showed that increased metabolic breakdown of epoxyeicosatrienoic acids by EPHX2 and impaired bioavailability of nitric oxide are tightly associated with impaired conduit artery endothelial function, independently of their blood pressure status [24]. This evidence concerns the gene EPHX2 and type 2 diabetes mellitus.